quinoxalines has been researched along with ergoline in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaddis, FG; Uretsky, NJ; Wallace, LJ | 1 |
| Elliott, P; Wallis, DI | 1 |
| Schmidt, WJ; Zadow, B | 1 |
| Frankenschmidt, A; Rump, LC; Schaible, U; Schollmeyer, PJ; Schuster, MJ; Schwertfeger, E | 1 |
| Bernardi, G; Calabresi, P; Mercuri, NB; Sancesario, G | 1 |
| Lamm, MC; Russell, VA; Taljaard, JJ | 1 |
| Bohmann, C; Riera-Knorrenschild, G; Rump, LC; Schollmeyer, P; Schwertfeger, E; Spillner, G | 1 |
| Kellermann, O; Launay, JM; Loric, S; Maroteaux, L | 1 |
| Matsubara, K; Ohtaki, K; Shimizu, K; Shiono, H | 1 |
9 other study(ies) available for quinoxalines and ergoline
| Article | Year |
|---|---|
AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cocaine; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Glutamine; Injections; Kainic Acid; Male; Motor Activity; Nerve Endings; Nucleus Accumbens; Quinoxalines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid | 1993 |
Glutamatergic and non-glutamatergic responses evoked in neonatal rat lumbar motoneurons on stimulation of the lateroventral spinal cord surface.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Bicuculline; Citalopram; Cocaine; Desipramine; Electric Stimulation; Ergolines; Evoked Potentials; Excitatory Amino Acid Antagonists; In Vitro Techniques; Ketanserin; Membrane Potentials; Motor Neurons; Quinoxalines; Rats; Rats, Wistar; Receptors, Glutamate; Serotonin Antagonists; Spinal Cord; Strychnine; Synapses | 1993 |
The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Drug Interactions; Ergolines; Haloperidol; Levodopa; Male; Pilot Projects; Quinoxalines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1994 |
Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Brimonidine Tartrate; Calcium; Dopamine Agents; Ergolines; Fenoldopam; Humans; In Vitro Techniques; Indoles; Kidney Cortex; Middle Aged; Norepinephrine; Oxidopamine; Pyridines; Quinoxalines; Quinpirole; Receptors, Dopamine D2; Sulpiride; Tetrodotoxin | 1993 |
Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Corpus Striatum; Denervation; Dopamine; Dopamine Agents; Ergolines; Male; Oxidopamine; Parkinson Disease, Secondary; Quinoxalines; Quinpirole; Rats; Rats, Wistar; Substantia Nigra; Synaptic Membranes; Tetrodotoxin | 1993 |
Lack of interaction between alpha 2-adrenoceptors and dopamine D2-receptors in mediating their inhibitory effects on [3H]dopamine release from rat nucleus accumbens slices.
Topics: Adrenergic alpha-Agonists; Animals; Apomorphine; Binding, Competitive; Brimonidine Tartrate; Dopamine; Electric Stimulation; Ergolines; GTP-Binding Proteins; Haloperidol; In Vitro Techniques; Male; Nucleus Accumbens; Pergolide; Quinoxalines; Quinpirole; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Dopamine D2; Signal Transduction; Sulpiride | 1993 |
Dopaminergic and alpha-adrenergic control of neurotransmission in human right atrium.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Aged; Benzazepines; Brimonidine Tartrate; Domperidone; Dopamine Agonists; Dopamine Antagonists; Electric Stimulation; Ergolines; Female; Fenoldopam; Heart Atria; Humans; In Vitro Techniques; Male; Methoxamine; Middle Aged; Norepinephrine; Prazosin; Quinoxalines; Quinpirole; Receptors, Adrenergic, alpha; Receptors, Dopamine; Sulpiride; Synaptic Transmission; Yohimbine | 1995 |
Sequential onset of three 5-HT receptors during the 5-hydroxytryptaminergic differentiation of the murine 1C11 cell line.
Topics: Animals; Antiparkinson Agents; Cells, Cultured; Colforsin; Cyclic AMP; Ergolines; Gene Expression; Quinoxalines; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Time Factors | 1996 |
Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Animals; Animals, Newborn; Azepines; Cabergoline; Caspases; Cell Count; Cycloheximide; Dizocilpine Maleate; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ergolines; Excitatory Amino Acid Antagonists; Herbicides; Immunohistochemistry; Mesencephalon; NADPH Dehydrogenase; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Organ Culture Techniques; Paraquat; Piperazines; Protein Synthesis Inhibitors; Quinoxalines; Rats; Rats, Wistar; Selegiline; Tyrosine 3-Monooxygenase | 2003 |